BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28759638)

  • 1. Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid.
    Alshehri S; Shakeel F; Ibrahim M; Elzayat E; Altamimi M; Shazly G; Mohsin K; Alkholief M; Alsulays B; Alshetaili A; Alshahrani A; Almalki B; Alanazi F
    PLoS One; 2017; 12(7):e0182011. PubMed ID: 28759638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat palatability, pharmacodynamics effect and bioavailability of mefenamic acid formulations utilizing hot-melt extrusion technology.
    Alshehri S; Shakeel F; Elzayat E; Almeanazel O; Altamimi M; Shazly G; Kazi M; Almutairy B; Alsulays B; Alshetaili A; Alalaiwe A; Repka M
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1610-1616. PubMed ID: 31311329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques.
    Alshehri SM; Shakeel F; Ibrahim MA; Elzayat EM; Altamimi M; Mohsin K; Almeanazel OT; Alkholief M; Alshetaili A; Alsulays B; Alanazi FK; Alsarra IA
    Saudi Pharm J; 2019 Feb; 27(2):264-273. PubMed ID: 30766439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and In Vivo Evaluation of Casein as a Drug Carrier for Enzymatically Triggered Dissolution Enhancement from Solid Dispersions.
    Bani-Jaber A; Alshawabkeh I; Abdullah S; Hamdan I; Ardakani A; Habash M
    AAPS PharmSciTech; 2017 Jul; 18(5):1750-1759. PubMed ID: 27752935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions.
    Andrews GP; Zhai H; Tipping S; Jones DS
    J Pharm Sci; 2009 Dec; 98(12):4545-56. PubMed ID: 19399827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: solid solution or epilayer?
    Lee EH; Byrn SR
    J Pharm Sci; 2010 Sep; 99(9):4013-22. PubMed ID: 20589947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
    Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F
    Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.
    Madan JR; Pawar AR; Patil RB; Awasthi R; Dua K
    Polim Med; 2018; 48(1):17-24. PubMed ID: 30657654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000.
    Aggarwal AK; Singh S
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1181-91. PubMed ID: 21449824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into Flufenamic Acid Cocrystal Dissolution in the Presence of a Polymer in Solution: from Single Crystal to Powder Dissolution.
    Guo M; Wang K; Qiao N; Fábián L; Sadiq G; Li M
    Mol Pharm; 2017 Dec; 14(12):4583-4596. PubMed ID: 29091446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
    Owusu-Ababio G; Ebube NK; Reams R; Habib M
    Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory Effects of Soluplus® on Flufenamic Acid β-Cyclodextrin Supramolecular Complex: Physicochemical Characterization and Pre-clinical Anti-inflammatory Assessment.
    Alshehri S; Imam SS; Altamimi MA; Hussain A; Shakeel F; Alshehri A
    AAPS PharmSciTech; 2020 May; 21(5):145. PubMed ID: 32430787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vivo evaluation of antihyperglycemic activity of microwave generated repaglinide solid dispersion.
    Zawar LR; Bari SB
    Chem Pharm Bull (Tokyo); 2012; 60(4):482-7. PubMed ID: 22466731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
    Xu WJ; Xie HJ; Cao QR; Shi LL; Cao Y; Zhu XY; Cui JH
    Drug Deliv; 2016; 23(1):41-8. PubMed ID: 24735247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicomponent Crystal of Mefenamic Acid and N-Methyl-d-Glucamine: Crystal Structures and Dissolution Study.
    Zaini E; Fitriani L; Sari RY; Rosaini H; Horikawa A; Uekusa H
    J Pharm Sci; 2019 Jul; 108(7):2341-2348. PubMed ID: 30779887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Dissolution of Luteolin by Solid Dispersion Prepared by Different Methods: Physicochemical Characterization and Antioxidant Activity.
    Alshehri S; Imam SS; Altamimi MA; Hussain A; Shakeel F; Elzayat E; Mohsin K; Ibrahim M; Alanazi F
    ACS Omega; 2020 Mar; 5(12):6461-6471. PubMed ID: 32258881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.
    Cao Y; Shi LL; Cao QR; Yang M; Cui JH
    Iran J Pharm Res; 2016; 15(2):385-94. PubMed ID: 27642309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of cefuroxime axetil solid dispersions using hydrophilic carriers.
    Gorajana A; Rajendran A; Yew LM; Dua K
    Int J Pharm Investig; 2015; 5(3):171-8. PubMed ID: 26258059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
    Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
    Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
    Potluri RH; Bandari S; Jukanti R; Veerareddy PR
    Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.